Please join us for a discussion of best practices for navigating the logistical aspects of launching and operating a European/Israeli-born business in America and setting and meeting expectations for U.S. later-stage funding.
Nancy Farestveit
nfarestveit@wsgr.comDaniel counsels UK and European tech and life sciences companies on U.S. expansion and fundraising.
Steve has represented non-U.S. and domestic companies in U.S. IPOs, global securities offerings, cross-border M&A, and SEC compliance for more than 25 years.
Craig represents companies, venture capital firms, and investment banks in private placements and public offerings. He also has M&A, technology licensing, and domestic and international joint venture experience.
Megan represents technology and life sciences clients in corporate transactional matters.